Fairvalue-Calculator Fairvalue-Calculator
EN DE

Adagio Medical Holdings (ADGM) Fair Value & Analysis

Healthcare · US · Market cap $16.9M

Price$0.6710
Fair Value$0.3700
Upside-44.9%
Quality95/100
Evidence: Low Range $0.2800 – $0.5600

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Adagio Medical Holdings (ADGM) currently trades at $0.6710, while our model-based Fair Value estimate is $0.3700 — implying the stock looks roughly 44.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -9% Boston Scientific Corporation (B1SX34) -83% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Adagio Medical Holdings (ADGM) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.3700 versus a price of $0.6710 — about −45% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ADGM?
Our 21-model fair value for Adagio Medical Holdings is $0.3700 (as of Jun 25, 2026), built from audited fundamentals. The current price is $0.6710.
What is the quality score of ADGM?
Adagio Medical Holdings has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.